How R&D partner diversity influences innovation performance: an empirical study in the nano-biopharmaceutical field

31Citations
Citations of this article
42Readers
Mendeley users who have this article in their library.
Get full text

Abstract

R&D partner diversity is generally acknowledged to help organizations to improve innovation performance. This study investigates the influence mechanism in depth by introducing technological diversification as mediator and the structural holes of new knowledge elements from R&D partners and the degree centrality of the focal organization’s knowledge elements as two moderators. The empirical analysis is based on patent data in the emerging nano-biopharmaceutical field and includes 554 innovative organizations. Results show that partners’ organizational diversity and geographical diversity have positive effects on focal organizations’ innovation performance through improving technological diversification. The structural holes of new knowledge elements from R&D partners and the degree centrality of the focal organization’s knowledge elements moderate the process in the way that when they are at high levels, the indirect positive effects of partner diversity on innovation performance through technological diversification are strengthened.

Cite

CITATION STYLE

APA

Zhang, G., & Tang, C. (2018). How R&D partner diversity influences innovation performance: an empirical study in the nano-biopharmaceutical field. Scientometrics, 116(3), 1487–1512. https://doi.org/10.1007/s11192-018-2831-6

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free